ASHBURN, Va., April 30 /PRNewswire/ -- Innocoll, Inc., a privately-held biopharmaceutical company, announced that the last of three planned phase 2 clinical trials sponsored by its wholly owned ...

This is a preview. Log in through your library . Abstract In an attempt to find the nontoxic topical dose of gentamicin for the cat, we studied the histological effects of topical gentamicin on the ...

Paromomycin topical cream with or without gentamicin is an effective treatment for ulcerative cutaneous leishmaniasis, according to the results of a phase 3, randomized, double-blind, parallel ...

In 1968-1969, there was an outbreak of colonization with gentamicin-resistant, Pseudomonas aeruginosa, pyocine type 5, in the burn service at Grady Hospital. Although the means by which resistance was ...

Gentamicin (Sternon-G) is an antibiotic, prescribed for severe bacterial infections. It works by killing the bacteria that causes infection. The information provided on this page is intended to serve ...

Paromomysin-based topical treatments were shown to be effective in curing cutaneous leishmaniasis (CL), according to a randomized, double blind study conducted in Panama. Leishmaniasis, transmitted by ...

Pharma ASHBURN, Va., Sept. 6 -- Innocoll, Inc. announced that it has agreed the sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European sales and marketing infrastructure to EUSA Pharma Inc., ...